Evaluation of Progression-Free Survival and Overall Survival of Epidermal Growth Factor Receptor-Positive Metastatic Lung Adenocarcinoma Patients Treated with Erlotinib
Details
The content you want is available to Zendy users.Already have an account? Click here. to sign in.